Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT00483951
Eligibility Criteria:
* ELIGIBILITY CRITERIA:
No one will be excluded from this study based on race, gender, or ethnicity.
A. General Inclusion Criteria:
* Age greater than or equal to 18
* Capable of giving informed consent.
B. General Exclusion Criteria:
* Pregnant women (uncertain patients will have urine or blood testing).
* Decompensated heart failure (unable to lie flat in bed).
Test Specific Exclusion Criteria:
A. CT Exclusion Criteria (excludes contrast enhanced CT scan only):
* Allergy to iodinated contrast agent excludes contrast enhanced CT research studies.
* Multiple myeloma.
* Patients with severe kidney disease (eGFR less than 30 mL/min/1.73 m(2).
B. Beta Antagonist Exclusions (excluded the use of beta blocker only):
* Asthma or severe chronic lung disease/emphysema with regular use of inhaler.
* Decompensated heart failure.
C. MRI Exclusion Criteria (excludes MRI scan only):
* Cardiac pacemaker or implantable defibrillator.
* Cerebral aneurysm clip.
* Neural stimulator (e.g. TENS-Unit).
* Any type of ear implant.
* Metal in eye (e.g. from machining).
* Any implanted device (e.g. insulin pump, drug infusion device).
D. Exclusions from MRI contrast agents:
* Lactating women unless they are willing to discard breast milk for 24 hours.
* Severe kidney disease (less than 30 mL/min/1.73 m(2).
E. Vasodilator Exclusions (excludes some vasodilator stress testing):
* Asthma or chronic obstructive pulmonary disease (emphysema) actively treated with bronchodilators or leukotriene receptor antagonists (albuterol, seravent, atrovent, montelukast singulair, zafirlukast Accolate. These conditions only exclude adenosine and dipyridamole.
* Second degree (Type II) and third degree atrioventricular heart block.
F. Exclusions from Dobutamine stress MRI only:
* Severe problems with heart rhythms.
* Severe high blood pressure.
G. Exclusion criteria for atropine (given during dobutamine stress echocardiography when target heart rate not achievable with dobutamine alone).
* Narrow angle glaucoma.
* Known or suspected severe bladder outlet obstruction due to prostatic hypertrophy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00483951
Study Brief:
Protocol Section:
NCT00483951